Showing results (21-30 of 49) with videos related to
Sort By:
Pageof 5
Pediatric Blood & Cancer|January 6, 2021
A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042)David Van Mater, Sridharan Gururangan, Oren Becher, et al.Neuro-Oncology|February 11, 2022
Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG RegistryMargot A Lazow, Martijn T Nievelstein, Adam Lane, et al.Neuro-Oncology|February 27, 2019
Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendationsZachary Miklja, Amy Pasternak, Stefanie Stallard, et al.Neuro-Oncology Advances|June 6, 2022
Pediatric pineoblastoma: A pooled outcome study of North American and Australian therapeutic dataJordan R Hansford, Jie Huang, Raelene Endersby, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2018
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 TrialEugene I Hwang, Marcel Kool, Peter C Burger, et al.Neuro-Oncology Practice|July 15, 2026
A multi-institutional report of children with atypical teratoid rhabdoid tumor treated with intensive multimodal therapyAshley S Margol, Lindsey M Hoffman, Rebecca Ronsley, et al.Frontiers in Oncology|September 23, 2024
Molecular characterization of gliomas and glioneuronal tumors amid Noonan syndrome: cancer predisposition examinedMargaret Shatara, Kathleen M Schieffer, Marilena Melas, et al.Neuro-Oncology|December 21, 2025
Phase 3 randomized trial of post-irradiation chemotherapy in patients with newly diagnosed ependymoma, a report from the Children's Oncology GroupAmy A Smith, Arzu Onar-Thomas, Shelly Lensing, et al.Acta Neuropathologica Communications|July 28, 2018
Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG RegistryHunter C Gits, Maia Anderson, Stefanie Stallard, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2025
Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005Bohyeon Yu, Cassie Kline, Owen Hoare, et al.Pageof 5